Bayview Legacy, Llc Sells 73,894 Shares of Arteris (NASDAQ:AIP) Stock

Arteris, Inc. (NASDAQ:AIP) major shareholder Bayview Legacy, Llc sold 73,894 shares of the company’s stock in a transaction on Monday, August 3rd. The stock was sold at an average price of $30.00, for a total transaction of $2,216,820.00. Following the transaction, the insider owned 8,355,177 shares of the company’s stock, valued at approximately $250,655,310. The trade was a 0.88% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available through this link. Major shareholders that own at least 10% of a company’s stock are required to disclose their sales and purchases with the SEC.

Bayview Legacy, Llc also recently made the following trade(s):

• On Tuesday, August 4th, Bayview Legacy, Llc sold 26,106 shares of Arteris stock. The shares were sold at an average price of $31.97, for a total transaction of $834,608.82.
• On Monday, July 6th, Bayview Legacy, Llc sold 125,976 shares of Arteris stock. The stock was sold at an average price of $35.79, for a total transaction of $4,508,681.04.
• On Thursday, July 2nd, Bayview Legacy, Llc sold 192,686 shares of Arteris stock. The stock was sold at an average price of $36.32, for a total transaction of $6,998,355.52.
• On Monday, June 8th, Bayview Legacy, Llc sold 70,000 shares of Arteris stock. The stock was sold at an average price of $34.91, for a total transaction of $2,443,700.00.
• On Friday, May 8th, Bayview Legacy, Llc sold 70,000 shares of Arteris stock. The shares were sold at an average price of $31.20, for a total transaction of $2,184,000.00.

Arteris Price Performance

Shares of AIP opened at $31.62 on Friday. The company has a current ratio of 0.73, a quick ratio of 0.73 and a debt-to-equity ratio of 0.17. Arteris, Inc. has a twelve month low of $8.42 and a twelve month high of $50.26. The firm has a market capitalization of $1.46 billion, a PE ratio of -40.03 and a beta of 1.96. The stock’s 50 day moving average is $36.06 and its two-hundred day moving average is $26.16.

Arteris (NASDAQ:AIP) last issued its earnings results on Thursday, August 6th. The company reported ($0.10) EPS for the quarter, missing the consensus estimate of ($0.04) by ($0.06). The business had revenue of $24.13 million for the quarter, compared to the consensus estimate of $23.48 million. Research analysts anticipate that Arteris, Inc. will post -0.58 earnings per share for the current year.

Key Headlines Impacting Arteris

Here are the key news stories impacting Arteris this week:

• Positive Sentiment: Arteris reported second-quarter revenue of $24.13 million, above the $23.48 million analyst consensus. More importantly, the company forecast third-quarter revenue of $24.0 million to $25.0 million and full-year 2026 revenue of $95.0 million to $98.0 million, both ahead of consensus estimates of $23.5 million and $94.2 million, respectively. The outlook suggests continued demand for Arteris’ semiconductor interconnect and system IP products. Arteris financial results and guidance
• Positive Sentiment: Roth Capital initiated coverage with a Buy rating and a $40 price target, while other analysts also maintain bullish targets. The new coverage adds support to the investment case and implies meaningful upside from recent trading levels. Roth Capital coverage
• Neutral Sentiment: Arteris appointed Saurabh Sinha as chief financial officer. The leadership change may improve investor focus on financial execution, although the announcement itself provides limited information about near-term earnings effects. Arteris CFO appointment
• Negative Sentiment: Second-quarter adjusted EPS was a loss of $0.10, missing the expected loss of $0.04 by $0.06. The larger-than-expected loss highlights ongoing profitability pressure despite the revenue beat. Arteris quarterly earnings
• Negative Sentiment: Several insiders reported sales, including CEO K. Charles Janac, Director Saiyed Atiq Raza, major shareholder Bayview Legacy, and Vice President Paul Alpern. While the sales represent relatively small portions of their remaining holdings in some cases, the concentration of insider selling could weigh on sentiment. Arteris insider selling

Analyst Ratings Changes

AIP has been the subject of a number of research analyst reports. TD Cowen increased their target price on shares of Arteris from $22.00 to $40.00 and gave the company a “buy” rating in a report on Wednesday, May 13th. Wall Street Zen lowered Arteris from a “buy” rating to a “hold” rating in a research note on Saturday, May 2nd. Jefferies Financial Group upped their price target on Arteris from $16.00 to $35.00 and gave the stock a “hold” rating in a report on Wednesday, May 13th. Rosenblatt Securities lifted their price objective on Arteris from $20.00 to $38.00 and gave the stock a “buy” rating in a report on Wednesday, May 13th. Finally, Weiss Ratings downgraded Arteris from a “sell (d-)” rating to a “sell (e+)” rating in a research report on Wednesday, May 13th. Four analysts have rated the stock with a Buy rating, one has issued a Hold rating and one has issued a Sell rating to the stock. Based on data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and an average price target of $38.50.

Institutional Inflows and Outflows

Several institutional investors have recently added to or reduced their stakes in AIP. AQR Capital Management LLC acquired a new stake in shares of Arteris during the 1st quarter worth about $1,621,000. Strs Ohio purchased a new stake in shares of Arteris during the first quarter worth about $104,000. Geode Capital Management LLC raised its position in shares of Arteris by 4.8% in the second quarter. Geode Capital Management LLC now owns 652,754 shares of the company’s stock valued at $6,222,000 after buying an additional 30,018 shares during the last quarter. Rhumbline Advisers lifted its stake in shares of Arteris by 35.8% during the second quarter. Rhumbline Advisers now owns 54,416 shares of the company’s stock valued at $519,000 after buying an additional 14,350 shares during the period. Finally, Arrowstreet Capital Limited Partnership lifted its stake in shares of Arteris by 8.6% during the second quarter. Arrowstreet Capital Limited Partnership now owns 320,332 shares of the company’s stock valued at $3,053,000 after buying an additional 25,448 shares during the period. Institutional investors and hedge funds own 64.36% of the company’s stock.

About Arteris

Arteris, Inc is a fabless semiconductor intellectual property (IP) company specializing in on-chip interconnect solutions and system IP for advanced integrated circuits. The company’s core products include its FlexNoC network-on-chip (NoC) fabrics, Ncore cache coherent interconnect IP, and CodaCache memory subsystem IP. These technologies enable semiconductor and systems companies to design scalable, energy-efficient chips for applications ranging from automotive and artificial intelligence (AI) to 5G communications and high-performance computing.

Founded in 2003 and headquartered in Santa Clara, California, Arteris serves a global customer base across North America, Europe, and Asia.